Bora Pharmaceuticals and Insilico Medicine Strike a $2.5 Billion AI Alliance
Bora Pharmaceuticals and Insilico Medicine unveiled a strategic alliance at BIO Asia-Taiwan worth a potential $2.5 billion, pairing Insilico's Pharma.AI discovery platform with Bora's global manufacturing and quality infrastructure. The deal signals AI drug developers pushing beyond molecule discovery into full-stack production partnerships.